Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared with Placebo in Adult Participants with Type 2 Diabetes, Moderate or Severe Renal Impairment with Inadequate..

Project: Research

Project Details

StatusActive
Effective start/end date02/13/2412/31/26

Funding

  • Lilly USA LLC: $30,661.00